Chrysalis Health and Curaechoice partner on no-cost mental health access

Chrysalis Health, one of the United States' larger outpatient mental health providers, has formed a commercial partnership with benefits-optimisation platform Curaechoice, giving the latter's members access to counselling, psychiatric services, and medication management at no cost through Chrysalis's network of more than 80 outpatient sites across nine states.

The deal extends Curaechoice's model of connecting self-funded employers to no-cost healthcare providers, adding mental health capacity across Florida, Ohio, Texas, South Dakota, North Dakota, Iowa, Minnesota, Nebraska, and Wyoming. Members can also access virtual behavioural health services in those states and in additional markets where Chrysalis operates telehealth.

The partnership

Curaechoice operates a multi-patented technology platform that routes plan members to in-network providers where the cost to the member is eliminated, with the aim of reducing out-of-pocket spend while allowing self-insured employers to better manage aggregate claims costs. Adding Chrysalis Health to its provider roster is presented by the company as a continuation of that approach into behavioural health, a category that has historically sat at the margins of employer benefits design.

Magin Perez, President of Chrysalis Health, said the arrangement would help "connect more employees and families with compassionate, evidence-based care while reducing the cost and access barriers that too often delay treatment."

Harsha Hatti, Chief Executive Officer of Curaechoice, argued that mental health care should be "as accessible as primary care," citing complexity and cost as the primary deterrents to treatment-seeking. The release cites Kaiser Family Foundation research suggesting 43% of insured adults who reported fair or poor mental health did not receive services they needed in the prior year, attributing the gap to difficulties finding trusted providers, navigation challenges, and stigma.

Market context

The employer-sponsored mental health benefits space has expanded considerably since the post-pandemic reappraisal of workforce wellbeing. A growing number of digital-health and managed care intermediaries now compete to place mental health capacity inside employer plans, including established telehealth platforms and newer direct-to-employer primary and behavioural care networks. The self-funded employer segment in particular has become a target for no-cost and value-based models, as plan sponsors seek to control trend while visibly improving member experience.

Chrysalis Health's physical footprint across mid-sized and rural states gives the partnership a differentiated element: many competing offerings lean heavily on virtual-only delivery, which can disadvantage plan members who prefer or require in-person care. Regulators and payers alike have placed growing emphasis on network adequacy in behavioural health following a series of enforcement actions and state-level parity findings in recent years.

Neither company disclosed financial terms, revenue-sharing arrangements, or the size of the employer and member populations covered by the agreement. Those figures would be the most useful signal of commercial scale, and their absence limits the ability to assess the partnership's significance relative to comparable network deals in the sector. Observers will watch whether Curaechoice extends this model into additional mental health provider groups as it builds out geographic coverage.